Current state-of-the-art antiplatelet and anticoagulation therapy in diabetic patients with coronary artery disease.
Future Cardiol
; 17(3): 521-534, 2021 05.
Article
in En
| MEDLINE
| ID: mdl-33728965
Lay abstract Patients with diabetes are at increased risk for heart diseases. In fact, heart attacks often occur silently in diabetic patients. Other complications, such as acute decrease in brain or limb perfusion, are also common especially in high-risk diabetic patients. Over the last decade, several drugs for the treatment of diabetes and its associated complications have emerged. Among these therapies, antithrombotic drugs play a pivotal role in preventing these accidents. However, the evidence on antithrombotic drugs use in prevention is limited due to the scarcity of studies dedicated to patients with diabetes. In this review, we provide an aerial view of the latest evidence on the optimal use of antithrombotic drugs in patients with diabetes and heart disease.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Coronary Artery Disease
/
Diabetes Mellitus
Type of study:
Clinical_trials
/
Guideline
Limits:
Humans
Language:
En
Journal:
Future Cardiol
Journal subject:
CARDIOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom